| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |